Latest news

Insights

Why Medical Affairs Teams Need New Skills for the Next Decade

Executive Summary Medical affairs has become one of the fastest-evolving functions in the pharmaceutical industry. Traditionally, medical affairs organizations focused on...
Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Lumvoa for the treatment of thyroid...
Commercial

Zymeworks to Acquire Theravance in $929 Million Deal

Zymeworks has agreed to acquire Theravance in a transaction valued at approximately $929 million, adding Theravance’s commercial products, royalty...
Clinical

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

AstraZeneca has released detailed results from two phase 3 studies of its investigational enzyme replacement therapy efzimfotase alfa for...
Clinical

AbbVie and Genmab Report Positive Phase 3 Results for Epkinly Combination in Diffuse Large B-Cell Lymphoma

AbbVie and Genmab have reported positive topline results from...
Clinical

Vistagen Misses Second Phase 3 Social Anxiety Trial but Sees Potential Path Forward

Vistagen has reported another setback for its lead anxiety...
Insights

Top 10 Trends Reshaping Biotech R&D Infrastructure

Executive Summary Biotechnology research and development is undergoing one of the most significant infrastructure transformations in its history. For decades, biotech...
Insights

The Rise of Multi-Omics in Drug Development

Executive Summary The pharmaceutical industry has always depended on a deeper understanding of human biology to drive therapeutic innovation. For decades,...
Clinical

Ollin Brings in $330M to Advance Eye Disease Drug Through Phase 3 Trial

Six months after reporting early clinical data that outperformed Genentech’s blockbuster eye therapy Vabysmo, Ollin Biosciences has secured $330...
Commercial

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

Flagship and Lean are looking to combine Lean's platform...
Manufacturing

ADC Therapeutics Announces Workforce Reduction as It Advances Zynlonta Regulatory Plans

ADC Therapeutics has announced a new restructuring plan that...
Insights

The Coming Talent Crisis in Life Sciences

Executive Summary The life sciences industry is entering one of the most significant workforce transitions in its history. For decades, pharmaceutical,...
Insights

How AI Is Changing the Economics of Drug Discovery

Executive Summary Drug discovery has long been one of the most expensive, time-consuming, and high-risk activities in modern business. Pharmaceutical companies...
Commercial

Biogen Pens $1B Deal to Acquire RayThera, Bagging Preclinical Immunology Assets

Biogen has agreed to acquire RayThera in a deal valued at up to $1 billion, gaining access to a...
Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug...
Editorial Team -
Commercial

Zymeworks to Acquire Theravance in $929 Million Deal

Zymeworks has agreed to acquire Theravance in a transaction...
Editorial Team -
Commercial

U.S. to buy additional $1B of Merck’s Covid-19 drug

In the latest Merck’s COVID-19 news, it was reported...
Commercial

Novartis spends €2.7 billion on acquiring MorphoSys

The recent buzz surrounding a potential bidding war for...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug...
Editorial Team -
Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug...
Commercial

Zymeworks to Acquire Theravance in $929 Million Deal

Zymeworks has agreed to acquire Theravance in a transaction...
Clinical

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

AstraZeneca has released detailed results from two phase 3...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

Research & Development

Market Access

Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Manufacturing

Viatris to Cut 10% of Workforce Following Strategic Review and Reports Fire at India Plant

Viatris has outlined plans to reduce its global workforce...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Why Medical Affairs Teams Need New Skills for the Next Decade

Executive Summary Medical affairs has become one of the fastest-evolving...
Editorial Team -
Commercial

Zymeworks to Acquire Theravance in $929 Million Deal

Zymeworks has agreed to acquire Theravance in a transaction...
Editorial Team -